PARP Inhibition in Ovarian Cancer: State of the Science

被引：5
|
作者：
Gunderson, Camille C. [1 ]
Moore, Kathleen N. [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 136卷 / 01期
关键词：
OPEN-LABEL; OLAPARIB; MULTICENTER; BRCA1;
D O I：
10.1016/j.ygyno.2014.12.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 50 条
  • [1] PARP inhibition in ovarian cancer
    Saul, Helen
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (12) : 2136 - 2136
  • [2] PARP Inhibition in Recurrent Ovarian Cancer
    Moore, Kathleen N.
    Pothuri, Bhavana
    Monk, Bradley
    Coleman, Robert L.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (10) : 647 - 655
  • [3] PARP inhibition and synthetic lethality in ovarian cancer
    Eskander, Ramez N.
    Tewari, Krishnansu S.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (05) : 613 - 622
  • [4] Rucaparib in the landscape of PARP inhibition in ovarian cancer
    Colomba, Emeline
    Pautier, Patricia
    Pommeret, Fanny
    Leary, Alexandra
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (06) : 437 - 446
  • [5] PARP Inhibition as Frontline Therapy in Ovarian Cancer
    Moore, Kathleen N.
    Pothuri, Bhavana
    Monk, Bradley
    Coleman, Robert L.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 550 - 556
  • [6] Maintenance Therapy With PARP Inhibition in Ovarian Cancer
    Herzog, Thomas J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (09) : 539 - 541
  • [7] Combined PARP and Immune Checkpoint Inhibition in Ovarian Cancer
    Lee, Elizabeth K.
    Konstantinopoulos, Panagiotis A.
    [J]. TRENDS IN CANCER, 2019, 5 (09): : 524 - 528
  • [8] PARP inhibition in ovarian cancer: what is still missing?
    Morotti, Matteo
    Ghisoni, Eleonora
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (01) : 143 - 145
  • [9] PARP inhibition: A promising therapeutic target in ovarian cancer
    Musella, A.
    Marchetti, C.
    Gasparri, M. L.
    Salerno, L.
    Casorelli, A.
    Domenici, L.
    Imperiale, L.
    Ruscito, I.
    Halim, T. Abdul
    Palaia, I.
    Di Donato, V.
    Pecorini, F.
    Monti, M.
    Muzii, L.
    Panici, P. B.
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (06) : 44 - 61
  • [10] Ovarian cancer: taking PARP inhibition one step further
    不详
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (SUPPL 6) : S139 - S140
12345